Escitalopram
- Generic Name
- Escitalopram
- Brand Names
- Cipralex, Lexapro
- Drug Type
- Small Molecule
- Chemical Formula
- C20H21FN2O
- CAS Number
- 128196-01-0
- Unique Ingredient Identifier
- 4O4S742ANY
- Background
Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic citalopram. It is used to restore serotonergic function in the treatment of depression and anxiety. Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with...
- Indication
Escitalopram is indicated for the acute and maintenance treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years old and older and for the acute treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years old and older. It is additionally indicated for symptomatic relief of obsessive-compulsive disor...
- Associated Conditions
- Anxiety, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD)
- Associated Therapies
- -
Depression-Diabetes Mechanisms: Urban African Americans
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-07-29
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT00209170
- Locations
- 🇺🇸
Grady Hospital Diabetes Clinic, Atlanta, Georgia, United States
The Effects of Increased Central Serotonergic Activity on Information Processing
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-09-19
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 40
- Registration Number
- NCT00206934
- Locations
- 🇩🇰
Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup, Glostrup, Denmark
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-05-27
- Target Recruit Count
- 42
- Registration Number
- NCT00209807
- Locations
- 🇪🇸
Hospital Universitari vall d'Hebron, Barcelona, Catalonia, Spain
Treatment Choices for Improving Adherence and Outcome
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2013-11-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 60
- Registration Number
- NCT00194948
- Locations
- 🇺🇸
Weill Medical College of Cornell University, White Plains, New York, United States
🇺🇸Cornell Internal Medicine Associates, New York, New York, United States
Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2011-02-18
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 30
- Registration Number
- NCT00190333
- Locations
- 🇫🇷
Louis Pradel Hospital, Bron, France
🇫🇷Henri Mondor Hospital, Creteil, France
🇫🇷Haut Lévèque Hospital, Pessac, France
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 97
- Registration Number
- NCT00183677
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
- Conditions
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 220
- Registration Number
- NCT00177671
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
- Conditions
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-01-12
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 319
- Registration Number
- NCT00177294
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-03-30
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 69
- Registration Number
- NCT00177216
- Locations
- 🇺🇸
Western Psychiatric Institute and Clinic/ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
- Conditions
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 133
- Registration Number
- NCT00166296
- Locations
- 🇪🇸
Fundacion Hospital Alcorcon, Alcorcon, Spain
🇪🇸Hospital Puerta de Hierro, Madrid, Spain
🇪🇸Hospital Nuestra Señora de Sonsoles, Avila, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.